Beta Drugs Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,260.00 -143.60 (-10.23%)Updated : 15 May 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 436.23 | 254.10 | 198.42 | 157.85 |
| Accumulated Depreciation Total | -54.61 | -43.30 | -35.71 | -26.76 |
| Other Liabilities Total | 9.41 | 6.27 | 5.55 | 4.71 |
| Long Term Debt | 126.99 | 6.04 | 6.97 | 11.83 |
| Common Stock Total | 10.09 | 9.61 | 9.61 | 9.61 |
| Other Current Assets Total | 0.00 | 0.00 | 0.58 | 0.01 |
| Prepaid Expenses | 1.01 | 0.52 | 0.33 | 0.31 |
| Total Assets | 436.23 | 254.10 | 198.42 | 157.85 |
| Current Portof LT Debt/ Capital Leases | 5.35 | 3.71 | 4.29 | 4.02 |
| Additional Paid- In Capital | 23.47 | 23.94 | 23.94 | 23.94 |
| Cash | 16.88 | 8.74 | 4.92 | 5.95 |
| Total Equity | 197.10 | 157.12 | 122.88 | 92.34 |
| Retained Earnings( Accumulated Deficit) | 163.53 | 123.56 | 89.33 | 58.79 |
| Total Common Shares Outstanding | 1.01 | 1.01 | 1.01 | 1.01 |
| Property/ Plant/ Equipment Total- Gross | 134.97 | 102.37 | 93.81 | 77.43 |
| Tangible Book Valueper Share Common Eq | 186.76 | 150.31 | 117.12 | 87.23 |
| Goodwill Net | 2.75 | 2.75 | 2.75 | 2.75 |
| Total Liabilities | 239.14 | 96.98 | 75.54 | 65.51 |
| Total Debt | 138.06 | 14.71 | 20.33 | 20.60 |
| Short Term Investments | 130.14 | 19.89 | 14.24 | 11.37 |
| Cashand Short Term Investments | 147.02 | 28.63 | 19.16 | 17.32 |
| Total Receivables Net | 117.88 | 92.32 | 71.42 | 53.10 |
| Notes Payable/ Short Term Debt | 5.71 | 4.96 | 9.07 | 4.75 |
| Accounts Receivable- Trade Net | 103.08 | 79.24 | 62.72 | 45.18 |
| Property/ Plant/ Equipment Total- Net | 80.36 | 59.20 | 58.09 | 50.67 |
| Total Current Liabilities | 102.73 | 84.67 | 63.02 | 48.97 |
| Total Inventory | 65.16 | 56.39 | 36.20 | 26.21 |
| Accounts Payable | 71.25 | 59.27 | 40.24 | 31.95 |
| Other Currentliabilities Total | 20.42 | 16.73 | 9.42 | 8.24 |
| Total Long Term Debt | 126.99 | 6.04 | 6.97 | 11.83 |
| Intangibles Net | 5.83 | 2.64 | 1.92 | 1.54 |
| Other Long Term Assets Total | 2.08 | 1.47 | 1.25 | 0.73 |
| Note Receivable- Long Term | 14.14 | 10.17 | 5.95 | 4.43 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 331.08 | 177.87 | 127.68 | 96.96 |
| Long Term Investments | - | 0.00 | 0.78 | 0.78 |
| Other Equity Total | - | - | 0.00 | 0.00 |
| Deferred Income Tax | - | - | 0.00 | 0.00 |
*All figures in crores except per share values
Beta Drugs Quick Links
Beta Drugs Dividend Beta Drugs Bonus Beta Drugs News Beta Drugs AGM Beta Drugs Rights Beta Drugs Splits Beta Drugs Board Meetings Beta Drugs Key Metrics Beta Drugs Shareholdings Beta Drugs Profit Loss Beta Drugs Cashflow Beta Drugs Q1 Results Beta Drugs Q2 Results Beta Drugs Q3 Results Beta Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
362.35+23.50(6.94%)
1,122.90+27.30(2.49%)
1,816.90+43.70(2.46%)
1,337.00-24.75 (-1.82%)
4,055.95-74.25 (-1.80%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.